In a randomized trial, dexamethasone was shown to improve Hamilton Depression Rating Scale scores in depressed patients compared to placebo over the course of 4 days (168), suggesting that impaired GR activation might contribute to symptoms of depression in some MDD patients. This evidence concerns the gene NR3C1 and depressive symptom measurement.